Are you a professional? Activate your profile

Are you already registered? Access Forgot your password?

Financial advisors
Calculation tools
- Calculates the risk and return of a securities portfolio
- Calculate your supplementary pension
News from the UK Stock Exchange

Funds / ETFs / Stock Ranking
Learn about finance
- Financial glossary
- Learning to invest
  The most important concepts of finance
Study Office
- Asset allocation
- Finance app ranking
About us

Constellation Pharmaceuticals Inc. - news published 27 - readings 378

BACK

Constellation Pharmaceuticals Inc.

Securities Termination Notice (SEC Filing - 15-12B)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-38584 Constellation Pharmaceuticals, Inc. (Exact na ...

26.07.2021

Constellation Pharmaceuticals Inc.

SEC Filing (4/A)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 23 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 23 July 2021 20:41:24 UTC .

23.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 22:46:18 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

SEC FORM 4SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 X Check this box if no lo ...

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:41:22 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:41:22 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

SEC.gov | Request Rate Threshold Exceeded U.S. Securities and Exchange Commission Your Request Originates from an Undeclared Automated Tool To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated tools. Your request has been identified as part of a network of automated tools outside of the acceptable policy and ...

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:41:22 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:36:22 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:36:22 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:31:12 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

The text version of this document is not available. You can access the original document here . Attachments Original document Permalink Disclaimer Constellation Pharmaceuticals Inc. published this content on 19 July 2021 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 19 July 2021 21:31:12 UTC .

19.07.2021

Constellation Pharmaceuticals Inc.

Notice of Effectiveness (SEC Filing - EFFECT)

19.07.2021

Constellation Pharmaceuticals Inc.

Post-Effective Amendment to Registration Statement (SEC Filing - POS AM)

As filed with the Securities and Exchange Commission on July 15, 2021 Registration No. 333-232992 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-232992 UNDER THE SECURITIES ACT OF 1933 CONSTELLATION PHARMACEUTICALS, INC. (Exact name of Registrant as specified in its charter) Dela ...

15.07.2021

Constellation Pharmaceuticals Inc. - news published 27 - readings 378

Constellation Pharmaceuticals Inc.

Securities Termination Notice (SEC Filing - 15-12B)

Constellation Pharmaceuticals Inc.

SEC Filing (4/A)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Insider Trading Report (SEC Filing - 4)

Constellation Pharmaceuticals Inc.

Notice of Effectiveness (SEC Filing - EFFECT)

Constellation Pharmaceuticals Inc.

Post-Effective Amendment to Registration Statement (SEC Filing - POS AM)

You have reached the maximum number of requests. You can no longer send.

Become Member

€2,99per month

Become Member

€2,99per month

You have reached the maximum
number of requests.
You can no longer send.

Become
Member

Become
Member